Phosphoric Acid

Phosphoric Acid

SCHEMBL303199

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ag+].[Ag+].[Ag+].[H+].[H+].[H+].[Na+].[Na+].[Na+].[Zr+4].[Zr+4].[Zr+4]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
SLC34A1 Q06495 1/20 0.36
KDM4E B2RXH2 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
CA1 P00915 2/20 0.30
CA4 P22748 2/20 0.30
CA5A P35218 2/20 0.30
CA5B Q9Y2D0 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL18066386 1.00
Phosphoric Acid SCHEMBL6542184 0.95 LMNA (0.40) LMNASLC34A1KDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL19210854 0.95 SLC34A1 (0.39) LMNASLC34A1
Phosphoric Acid SCHEMBL2554263 0.95
Phosphoric Acid SCHEMBL917601 0.95 LMNA (0.40) LMNASLC34A1KDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL303198 0.90
Phosphoric Acid SCHEMBL293348 0.89 SLC34A1 (0.42) LMNASLC34A1
Phosphoric Acid SCHEMBL29608831 0.89
Phosphoric Acid SCHEMBL11659 0.89
Phosphoric Acid SCHEMBL7525209 0.89 LMNA (0.43) LMNASLC34A1KDM4ECYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230380425-A1 COLORLESS ANTIMICROBIAL COMPOSITION ARGAMAN TECHNOLOGIES LTD. (IL) 2023-11-30 US claimed
US-20230348647-A1 Denture Material Having Anti-Microbial Properties JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) 2023-11-02 US claimed
US-20230314064-A1 REFRIGERATOR LG ELECTRONICS INC. (KR) 2023-10-05 US claimed
US-11708442-B2 Denture material having anti-microbial properties JAMES R. GLIDEWELL DENTAL CERAMICS, INC. (US) 2023-07-25 US claimed
US-20230217921-A1 DECORATIVE PANEL HAVING ANTIMICROBIAL PROPERTIES FLOORING INDUSTRIES LIMITED, SARL (LU) 2023-07-13 US claimed
WO-2023281365-A1 ANTIBACTERIAL AND ANTIVIRAL TREATMENT FOR COINS, BANKNOTES AND TOKENS L & G HOLDING S.R.L. (IT) 2023-01-12 WO claimed
WO-2022084997-A1 COLORLESS ANTIMICROBIAL COMPOSITION ARGAMAN TECHNOLOGIES LTD. (IL) 2022-04-28 WO claimed
WO-2021250487-A1 DECORATIVE PANEL WITH ANTIMICROBIAL PROPERTIES FLOORING INDUSTRIES LIMITED, SARL (LU) 2021-12-16 WO claimed
EP-3017699-B1 ANTIMICROBIAL CABLE TIE THOMAS & BETTS INT LLC (US) 2020-07-29 EP claimed
US-10138038-B2 Antimicrobial detectable cable tie THOMAS & BETTS INTERNATIONAL, LLC (US) 2018-11-27 US claimed
US-20040185748-A1 ANTIMICROBIAL BRA GENDEL KATHLEEN (US) 2004-09-23 US claimed
US-6786798-B1 Antimicrobial bra GENDEL KATHLEEN (US) 2004-09-07 US claimed
JP-2004517704-A 2004-06-17 JP claimed
US-20040086549-A1 Advantage in using the silver ion as antiseptic agent is the general lack of formation of bacterial tolerance COLOPLAST A/S (DK) 2004-05-06 US claimed
EP-1372745-A2 MEDICAL DRESSING COMPRISING AN ANTIMICROBIAL SILVER COMPOUND COLOPLAST A/S (DK) 2004-01-02 EP claimed
WO-2003099543-A1 ANTIMICROBIAL FILM STRUCTURES FOR USE IN HVAC PECHINEY EMBALLAGE FLEXIBLE EUROPE (FR) 2003-12-04 WO claimed
US-20030215589-A1 Antimicrobial film structures for use in HVAC PECHINEY EMBALLAGE FLEXIBLE EUROPE (FR) 2003-11-20 US claimed
EP-1357951-A1 A MEDICAL DRESSING COMPRISING AN ANTIMICROBIAL SILVER COMPOUND COLOPLAST A/S (DK) 2003-11-05 EP claimed
WO-2002078755-A2 MEDICAL DRESSING COMPRISING AN ANTIMICROBIAL SILVER COMPOUND COLOPLAST A/S (DK) 2002-10-10 WO claimed
WO-2002062403-A1 A MEDICAL DRESSING COMPRISING AN ANTIMICROBIAL SILVER COMPOUND COLOPLAST A/S (DK) 2002-08-15 WO claimed